首页> 美国卫生研究院文献>other >Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma

【2h】

Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma

机译：索拉非尼单药治疗与基于索拉非尼的局部治疗在晚期肝细胞癌中的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundAlthough sorafenib is accepted as the standard of care in advanced hepatocellular carcinoma (HCC), its therapeutic benefit is marginal. Here, we aimed to compare the efficacy and safety of sorafenib monotherapy (S-M) and sorafenib-based loco-regional treatments (S-LRTs) in advanced HCC.

机译：背景尽管索拉非尼已被接受为晚期肝细胞癌（HCC）的治疗标准，但其治疗益处微乎其微。在这里，我们旨在比较索拉非尼单药治疗（S-M）和基于索拉非尼的局部区域治疗（S-LRTs）在晚期HCC中的疗效和安全性。

著录项

期刊名称 other
作者
Sangheun Lee; Beom Kyung Kim; Seung Up Kim; Yehyun Park; Sooyun Chang; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Chae Yoon Chon; Kwang-Hyub Han;
展开▼
作者单位

展开▼
年(卷),期 -1(8),10
年度 -1
页码 e77240
总页数 8
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature [J] . Abdel-RahmanO., FouadM. Critical reviews in oncology/hematology . 2014,第1期

机译：基于索拉非尼的组合作为晚期肝细胞癌的一线治疗：文献的系统评价
2. Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients [J] . Won Young Tak, Baek-Yeol Ryoo, Ho Yeong Lim, Investigational new drugs. . 2018,第6期

机译：第一线组合治疗与索拉非尼蛋白酶，口服HDAC抑制剂，对东亚患者晚期肝细胞癌的索拉非尼治疗，对索拉非尼抑制剂的第一线组合治疗研究
3. Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study [J] . Yizhuo Wang, Qing Gou, Rongde Xu, OncoTargets and therapy . 2018,第1期

机译：索拉非尼与阿帕替尼治疗中，晚期肝细胞癌的疗效和安全性：一项回顾性比较研究
4. Magnetically Targeted Delivery of Sorafenib Through Magnetic Solid Lipid Nanoparticles Towards Treatment of Hepatocellular Carcinoma [C] . F. Vischio, N. Depalo, R. M. Iacobazzi, NATO Advanced Study Institute on Detection, Diagnosis and Health Concerns of Toxic Chemical and Biological Agents . 2020

机译：通过磁性固体脂质纳米粒子致磁性固体脂质纳米粒子对肝细胞癌治疗的磁性靶向递送
5. Poly(lactide-co-glycolide) Microspheres for Localized, Magnetic Resonance Imaging Monitored, Transcatheter Delivery of Sorafenib to Hepatocellular Carcinoma. [D] . Chen, Jeane. 2015

机译：聚（丙交酯-共-乙交酯）微球体用于局部监测，磁共振成像监测，索拉非尼经导管输送至肝细胞癌。
6. Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study [O] . Yizhuo Wang, Qing Gou, Rongde Xu, 2018

机译：索拉非尼和阿帕替尼治疗中晚期肝细胞癌的疗效和安全性：一项回顾性比较研究
7. Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma. [O] . Sangheun Lee, Beom Kyung Kim, Seung Up Kim, 2013

机译：索拉非尼单药治疗与索拉非尼为基础的局部区域治疗对晚期肝细胞癌的疗效。

Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅